Wedbush Downgrades BioMimetic Therapeutics (BMTI) to Neutral, Still See Approval of Augment Bone Graft
Go back to Wedbush Downgrades BioMimetic Therapeutics (BMTI) to Neutral, Still See Approval of Augment Bone Graft| BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) | Delayed: 9.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.49 | 52 Week High | $9.56 | |||
| Open | $9.49 | 52 Week Low | $2.01 | |||
| Day High | $9.49 | P/E | N/A | |||
| Day Low | $9.49 | EPS | $-0.97 | |||
| Volume | 1,100 | |||||
